These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36806581)

  • 1. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
    Kam CS; Ho DW; Ming VS; Tian L; Sze KM; Zhang VX; Tsui YM; Husain A; Lee JM; Wong CC; Chan AC; Cheung TT; Chan LK; Ng IO
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1325-1350. PubMed ID: 36806581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4.
    Shu Y; Lu Y; Pang X; Zheng W; Huang Y; Li J; Ji J; Zhang C; Shen P
    Oncotarget; 2016 Nov; 7(47):76984-76994. PubMed ID: 27769068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
    Ros S; Flöter J; Kaymak I; Da Costa C; Houddane A; Dubuis S; Griffiths B; Mitter R; Walz S; Blake S; Behrens A; Brindle KM; Zamboni N; Rider MH; Schulze A
    Oncogene; 2017 Jun; 36(23):3287-3299. PubMed ID: 28092678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
    Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
    Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
    Minchenko O; Opentanova I; Minchenko D; Ogura T; Esumi H
    FEBS Lett; 2004 Oct; 576(1-2):14-20. PubMed ID: 15474002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
    Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
    Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor β1 upregulates 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-4 expression in A549 and MCF-10A cells.
    Altunok TH; Muchut RJ; Iglesias AA; Yalcin A
    Cell Biochem Funct; 2023 Dec; 41(8):1220-1229. PubMed ID: 37707291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines.
    Minchenko OH; Opentanova IL; Ogura T; Minchenko DO; Komisarenko SV; Caro J; Esumi H
    Acta Biochim Pol; 2005; 52(4):881-8. PubMed ID: 16025159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
    Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
    Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA FIRRE contributes to the proliferation and glycolysis of hepatocellular carcinoma cells by enhancing PFKFB4 expression.
    Shen C; Ding L; Mo H; Liu R; Xu Q; Tu K
    J Cancer; 2021; 12(13):4099-4108. PubMed ID: 34093813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
    Li X; Wu L; Zopp M; Kopelov S; Du W
    Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
    Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
    Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma.
    Chan LK; Ho DW; Kam CS; Chiu EY; Lo IL; Yau DT; Cheung ET; Tang CN; Tang VW; Lee TK; Wong CC; Chok KS; Chan AC; Cheung TT; Wong CM; Ng IO
    J Hepatol; 2021 Feb; 74(2):360-371. PubMed ID: 32918955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Alternative Splice Variants of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-4 in Normoxic and Hypoxic Melanoma Cells.
    Trojan SE; Dudzik P; Totoń-Żurańska J; Laidler P; Kocemba-Pilarczyk KA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
    Gao R; Liu Y; Li D; Xun J; Zhou W; Wang P; Liu C; Li X; Shen W; Su W; Qiao H; Stupack DG; Luo N
    Cell Physiol Biochem; 2018; 50(6):2108-2123. PubMed ID: 30415245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
    Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
    J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism.
    Li B; Takeda K; Ishikawa K; Yoshizawa M; Sato M; Shibahara S; Furuyama K
    Tohoku J Exp Med; 2012 Sep; 228(1):27-41. PubMed ID: 22892400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening.
    Strohecker AM; Joshi S; Possemato R; Abraham RT; Sabatini DM; White E
    Oncogene; 2015 Nov; 34(45):5662-76. PubMed ID: 25772235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma.
    Dong F; Li R; Wang J; Zhang Y; Yao J; Jiang SH; Hu X; Feng M; Bao Z
    J Exp Clin Cancer Res; 2021 Apr; 40(1):121. PubMed ID: 33832535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
    Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
    Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.